156 related articles for article (PubMed ID: 35470199)
1. Efficacy of open dialogue about complementary and alternative medicine compared with standard care in improving quality of life in patients undergoing conventional oncology treatment (CAMONCO 2): protocol for a randomised controlled trial.
Stie M; Delmar C; Nørgaard B; Jensen LH
BMJ Open; 2022 Apr; 12(4):e059960. PubMed ID: 35470199
[TBL] [Abstract][Full Text] [Related]
2. Impact of Open Dialogue about Complementary Alternative Medicine-A Phase II Randomized Controlled Trial.
Stie M; Delmar C; Nørgaard B; Jensen LH
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205698
[TBL] [Abstract][Full Text] [Related]
3. A complex nursing intervention of complementary and alternative medicine (CAM) to increase quality of life in patients with breast and gynecologic cancer undergoing chemotherapy: study protocol for a partially randomized patient preference trial.
Klafke N; Mahler C; von Hagens C; Rochon J; Schneeweiss A; Müller A; Salize HJ; Joos S
Trials; 2015 Feb; 16():51. PubMed ID: 25887713
[TBL] [Abstract][Full Text] [Related]
4. Towards an open and effective dialogue on complementary medicine in oncology: protocol of patient participatory study 'COMMON'.
Mentink M; Noordman J; Busch M; van Vliet L; Timmer-Bonte JA; van Dulmen S
BMJ Open; 2021 Oct; 11(10):e053005. PubMed ID: 34670766
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of smartphone-based virtual reality relaxation in providing comfort to patients with cancer undergoing chemotherapy in oncology outpatient setting in Indonesia: protocol for a randomised controlled trial.
Gautama MSN; Haryani H; Huang TW
BMJ Open; 2023 Jul; 13(7):e074506. PubMed ID: 37491084
[TBL] [Abstract][Full Text] [Related]
6. Multimodality local consolidative treatment versus conventional care of advanced lung cancer after first-line systemic anti-cancer treatment: study protocol for the RAMON multicentre randomised controlled trial with an internal pilot.
Beard C; Rogers CA; Fleming L; Conibear J; Evison M; Newsom-Davis T; Barwick T; Mills N; Stokes EA; De Sousa P; Batchelor T; Rawlinson J; Baos S; Harris R; Lim E
BMJ Open; 2023 Dec; 13(12):e081650. PubMed ID: 38072470
[TBL] [Abstract][Full Text] [Related]
7. Open dialogue about complementary and alternative medicine (CAM) integrated in conventional oncology care, characteristics and impact. A systematic review.
Stie M; Jensen LH; Delmar C; Nørgaard B
Patient Educ Couns; 2020 Nov; 103(11):2224-2234. PubMed ID: 32563705
[TBL] [Abstract][Full Text] [Related]
8. Explore the use of complementary and alternative medicine among Chinese gynaecological patients with cancer undergoing chemotherapy: a qualitative phenomenological study.
Zhang J; Luo B; Liu X; He Y; Zuo Y
BMJ Open; 2023 Dec; 13(12):e074313. PubMed ID: 38114285
[TBL] [Abstract][Full Text] [Related]
9. Use of decision aid to improve informed decision-making and communication with physicians on the use of oral complementary and alternative medicine (CAM) among cancer patients on chemotherapy treatment: a randomised controlled trial.
Chong WQ; Mogro MJ; Arsad A; Tai BC; Lee SC
Support Care Cancer; 2021 Jul; 29(7):3689-3696. PubMed ID: 33188612
[TBL] [Abstract][Full Text] [Related]
10. Nurse-led, screening-triggered, early specialised palliative care intervention programme for patients with advanced lung cancer: study protocol for a multicentre randomised controlled trial.
Fujisawa D; Umemura S; Okizaki A; Satomi E; Yamaguchi T; Miyaji T; Mashiko T; Kobayashi N; Kinoshita H; Mori M; Morita T; Uchitomi Y; Goto K; Ohe Y; Matsumoto Y
BMJ Open; 2020 Nov; 10(11):e037759. PubMed ID: 33243791
[TBL] [Abstract][Full Text] [Related]
11. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
[TBL] [Abstract][Full Text] [Related]
12. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
15. Telephone interventions for symptom management in adults with cancer.
Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
[TBL] [Abstract][Full Text] [Related]
16. Decongestive progressive resistance exercise with an adjustable compression wrap for breast cancer-related lymphoedema (DREAM): protocol for a randomised controlled trial.
Al Onazi MM; Campbell KL; Thompson RB; Ghosh S; Mackey JR; Muir A; McNeely ML
BMJ Open; 2022 Apr; 12(4):e053165. PubMed ID: 35379618
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of the effectiveness of complementary and alternative medicine on nausea and vomiting in children with cancer: a study protocol.
Ho KY; Lam KKW; Chung JOK; Xia W; Cheung AT; Ho LK; Chiu SY; Chan GCF; Li HCW
BMJ Open; 2019 Oct; 9(10):e031834. PubMed ID: 31628132
[TBL] [Abstract][Full Text] [Related]
18. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
19. Investigating survival, quality of life and cognition in PROton versus photon therapy for
Heggebø LC; Borgen IMH; Rylander H; Kiserud C; Nordenmark TH; Hellebust TP; Evensen ME; Gustavsson M; Ramberg C; Sprauten M; Magelssen H; Blakstad H; Moorthy J; Andersson K; Raunert I; Henry T; Moe C; Granlund C; Goplen D; Brekke J; Johannessen TA; Solheim TS; Marienhagen K; Humberset Ø; Bergström P; Agrup M; Dahl L; Gubanski M; Gojon H; Brahme CJ; Rydén I; Jakola AS; Vik-Mo EO; Lie HC; Asphaug L; Hervani M; Kristensen I; Rueegg CS; Olsen IC; Ledal RJ; Degsell E; Werlenius K; Blomstrand M; Brandal P
BMJ Open; 2023 Mar; 13(3):e070071. PubMed ID: 36940951
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
